In addition, ddPCR-based detection of early (clonal) mutations such as IDH mutation, TERT promoter mutation and chromosomal losses like 1p/19q codeletion or chromosome 10 deletion may serve as an objective means to assess tumor cell content in a given tissue sample more accurately than microscopic evaluation. The gene discussed is TERT; the disease is neoplasm.